Search details
1.
African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.
J Urol
; 202(2): 247-255, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31107158
2.
Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
Cancer
; 122(22): 3529-3537, 2016 Nov 15.
Article
in English
| MEDLINE | ID: mdl-27479362
3.
Management of Oropharyngeal Cancer in the HPV Era.
Cancer Control
; 23(3): 197-207, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27556659
4.
Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
Int J Radiat Oncol Biol Phys
; 117(2): 341-347, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37105404
5.
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
Int J Radiat Oncol Biol Phys
; 116(3): 533-543, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36549347
6.
Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization.
J Gastrointest Oncol
; 9(3): 546-552, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29998020
7.
Patient choice for high-volume center radiation impacts head and neck cancer outcome.
Cancer Med
; 7(10): 4964-4979, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30175512
8.
Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource Settings.
Int J Radiat Oncol Biol Phys
; 99(2): 378-382, 2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28871987
9.
The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy.
J Contemp Brachytherapy
; 8(5): 386-390, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27895679
10.
Treatment delays, race, and outcomes in head and neck cancer.
Cancer Epidemiol
; 45: 18-25, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27664388
Results
1 -
10
de 10
1
Next >
>>